Dynavax Technologies Corp
NASDAQ:DVAX
Dynavax Technologies Corp
NASDAQ:DVAX
Price:
11.9 USD
-1.33%
Updated:
Jun 10, 2024
Dynavax Technologies Corp
Research & Development
|
Dynavax Technologies Corp
Research & Development Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dynavax Technologies Corp
NASDAQ:DVAX
|
Research & Development
-$54.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-1%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-14%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Research & Development
-$4.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-17%
|
See Also
What is Dynavax Technologies Corp's Research & Development?
Research & Development
-54.7m
USD
-54.7m
USD
Based on the financial report for Mar 31, 2024, Dynavax Technologies Corp's Research & Development amounts to -54.7m USD.
What is Dynavax Technologies Corp's Research & Development growth rate?
Research & Development CAGR 10Y
-1%
-1%
Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for Dynavax Technologies Corp have been -20% over the past three years , 10% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
